Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1993 1
1994 3
1995 1
1996 3
1997 1
1999 2
2000 2
2001 7
2002 2
2003 8
2004 3
2005 2
2006 7
2007 9
2008 6
2009 4
2010 2
2011 5
2012 1
2013 2
2014 4
2018 3
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 17872866

79 results
Results by year
Filters applied: . Clear all
Page 1
Rebuttal: should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? No.
Aaron SD. Aaron SD. Can Fam Physician. 2007 Sep;53(9):1429-30, 1432. Can Fam Physician. 2007. PMID: 17872866 Free PMC article. No abstract available.
Rebuttal: should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? Yes.
Salpeter SR. Salpeter SR. Can Fam Physician. 2007 Sep;53(9):1429-30, 1432-3. Can Fam Physician. 2007. PMID: 17872865 Free PMC article. No abstract available.
Tiotropium in combination with placebo, salmeterol, or fluticasone salmeterol for chronic obstructive pulmonary disease: possible confounding effect of treatment withdrawal?
Brown SM. Brown SM. Ann Intern Med. 2007 Dec 18;147(12):882; author reply 882-3. doi: 10.7326/0003-4819-147-12-200712180-00011. Ann Intern Med. 2007. PMID: 18087061 No abstract available.
Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? NO.
Aaron SD. Aaron SD. Can Fam Physician. 2007 Aug;53(8):1290-2, 1294-7. Can Fam Physician. 2007. PMID: 17872839 Free PMC article. No abstract available.
Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? YES.
Salpeter SR. Salpeter SR. Can Fam Physician. 2007 Aug;53(8):1290-7. Can Fam Physician. 2007. PMID: 17872838 Free PMC article. No abstract available.
[New studies refute steroid opponents. COPD--after all a case for corticosteroids?].
Calverley P. Calverley P. MMW Fortschr Med. 2003 Jun 12;145(24):20. MMW Fortschr Med. 2003. PMID: 12866294 German. No abstract available.
Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
Cazzola M, Centanni S, Boveri B, Di Marco F, Santus P, Matera MG, Allegra L. Cazzola M, et al. Respiration. 2001;68(5):452-9. doi: 10.1159/000050550. Respiration. 2001. PMID: 11694805 Clinical Trial.
A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease.
Matera MG, Caputi M, Cazzola M. Matera MG, et al. Respir Med. 1996 Sep;90(8):497-9. doi: 10.1016/s0954-6111(96)90178-x. Respir Med. 1996. PMID: 8869445 Free article. Clinical Trial. No abstract available.
[Inhalation combination therapy in chronic obstructive lung disease. TRISTAN-study].
Seeger W, Schulz R. Seeger W, et al. Internist (Berl). 2004 Jun;45(6):727-8. doi: 10.1007/s00108-004-1177-8. Internist (Berl). 2004. PMID: 15138641 Clinical Trial. German. No abstract available.
A word of caution regarding a new long-acting bronchodilator.
Bone RC. Bone RC. JAMA. 1994 May 11;271(18):1447-8. JAMA. 1994. PMID: 7909854 No abstract available.
79 results
Jump to page
Feedback